You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Generic Companies with Tentative Approvals for: Lupin Ltd

✉ Email this page to a colleague

« Back to Dashboard

Lupin Ltd Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Generic Name	NDA	Strength	Dosage Form
Lupin Ltd	dolutegravir;rilpivirine	213120	50MG/25MG	TABLET;ORAL
Lupin Ltd	rivaroxaban	208555	0.2%	INJECTABLE;INJECTION
Lupin Ltd	tenofovir disoproxil fumarate	204402	150MG	TABLET;ORAL
Lupin Ltd	hydrochlorothiazide; irbesartan	201524	12.5MG;150MG	TABLET;ORAL
Lupin Ltd	tenofovir disoproxil fumarate	204402	200MG	TABLET;ORAL
Lupin Ltd	milnacipran hydrochloride	205286	50MG	TABLET;ORAL
>Applicant	>Generic Name	>NDA	>Strength	>Dosage Form

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.